维普中文期刊产品整合服务
31篇 您的检索式:作者名="Boghaert"
    题名 作者 年代 出处 被引量
1Antibody targetedchemotherapy with CMC-544: a CD22-targeted immunoconjugate ofcalicheamicin for the treatment of B-lymphoid malignancies 显示文摘Dijoseph JF Armellino DC Boghaert ER 2004Blood2004,103,5:1
2Antibody-Targeted Chemotherapy with the Calicheamicin Conjugate hu3S193-N-Acetyl Calicheamicin Dimethyl Hydrazide Targets Lewisyand Eliminates Lewis'y-Positive Human Carcinoma Cells and Xenografts显示文摘Erwin R Boghaert Latha Sridharan 2004Cllnical Cancer Research J2004,10,1:1
3Reduced expression of EphrinA1 (EFNAI) inhibits three-dimensional growth of HT29 colon carcinoma cells 显示文摘POTLA L BOGHAERT ER ARMELLINO D 2002Cancer Lett2002,175,2:1
4Reduced expression of EphrinA1 (EFNA1) inhibits three dimensional growth of HT29 colon carcinoma cells显示文摘Potla L Boghaert E R Armellino D 2002Cancer Lett2002,175,2:1
5Reduced expression of EphrinA1 (EFNA1) inhibits three dimensional growth of HT29 colon carcinoma cells显示文摘Lyka Potla Erwin R Boghaert 2002Cancer Let2002,175,2:1
6Antibody - targeted chemotherapy with the calicheamicin conjugate hu3S193 - N - acetyl gamma calicheamicin dimethyl hydrazide targets Lewisy and eliminates Lewisy -positive human carcinoma cells and xenografts 显示文摘Boghaert ER Sridharan L Armellino DC 2004Clin Cancer Res2004,10,13:1
7Snaill,Snail2,and E47 promote mammaryepithelial branching morphogenesis 显示文摘Lee K Gjorevski N Boghaert E 2011EMBO J2011,30,13:1
8Reduction of translation initiation factor 4E decreases the malignancy of ras-transformed cloned rat embryo fibroblasts显示文摘Graff JR Boghaert ER De Benedetti A 1995Int J Cancer1995,60,2:1
9ABT-199,apotent and selective BCL-2inhibitor,achieves antitumor activity while sparing platelets显示文摘SOUERS A J LEVERSON J D BOGHAERT E R 2013Nat Med2013,19,:1
10Reduction of translation initiation factor 4E decreases the malignancy of ras-transformed cloned rat embryo fibroblasts显示文摘Graff J R Boghaert E R De Benedetti A 1995Int J Cancer1995,60,2:1
11ABT-199,a potent and selective BCL-2 inhibitor,achieves antitumor activity while sparing platelets显示文摘Souers AJ Leverson JD Boghaert ER 2013Nat Med2013,19,2:1
12Reduction of traslation initiation factor 4E decrease the malignancy of ras-transformed cloned rat embryo fibroblasts显示文摘 Boghaert E De Benedetti AD 1995Int J Cancer1995,60,:1
13ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets显示文摘Souers AJ Leverson JD Boghaert ER 2013Nat Med2013,19,2:1
14Antibody- targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies 显示文摘DiJoseph JF Armellino DC Boghaert ER 2004Blood2004,103,5:1
15Reduction of traslation initiation factor 4E decreases the malignancy of rastransformed cloned rat embryo fibroblasts显示文摘Graff JR Boghaert ER De Benedetti A 1995Int J Cancer1995,60,2:1
16ABT-199,apotent and selective BCL-2inhibitor,achieves antitumor activity while sparing platelets显示文摘Souers AJ Leverson JD Boghaert ER 2013Nat Med2013,19,:1
17Reduction of translation initiation factor 4E decreases the malignancy of ras- transformed cloned rat embryo fibroblasts 显示文摘Graff JR Boghaert ER De Benedetti A 1995Int J Cancer1995,60,2:1
18Antibody-targeted chemotherapy with the calicheamicin conjugate hu3S193-N-acetyl gamma caliehemaicin dimethyl hydrazide targets Lewisy and eliminates Lewisy-positive human carcinoma cells and xenografts显示文摘BOGHAERT ER SRIDHARAN L ARMELLINO DC 2004Clin Cancer Res2004,10,13:1
19Tumoricidal effect of calicheamicin immuno-conjugates using a passive targeting strategy显示文摘BOGHAERT ER KHANDKE K SRIDHARAN L 2006Int J Oncol2006,28,3:1
20Antibody-targeted chemotherapy with CMC-544:a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies显示文摘DUOSEPH JF ARMELLINO DC BOGHAERT ER 2004Blood2004,103,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费